A new review published on Aug. 6 brings together recent advances in the understanding of Ménière's disease, providing insights into the biological mechanisms that may underlie this inner ear disorder and suggesting potential paths for diagnosis, modeling, and treatment.
The article proposes that the endolymphatic sac—a structure responsible for maintaining the inner ear environment—could be a central site where multiple factors associated with Ménière's disease converge. This hypothesis aims to explain the diverse symptoms experienced by patients.
Ménière's disease is described as a chronic condition marked by recurring episodes of vertigo, fluctuating hearing loss, tinnitus, and a sensation of fullness in the ear. Despite being recognized for over a century, its cause has remained uncertain. The review says that instead of resulting from a single mechanism, Ménière's disease is likely influenced by genetic susceptibility, immune dysfunction, viral infection, inflammation, impaired ion regulation, and abnormalities in inner ear fluid balance. These factors may disrupt the function of the endolymphatic sac and lead to endolymphatic hydrops—the hallmark pathological feature of the condition.
The article also discusses current animal models used to study Ménière's disease. While these models have improved understanding of underlying mechanisms, none fully replicates the fluctuating symptoms seen in patients. The review suggests combining surgical, biological, and genetic approaches to create more representative models that could speed up therapy development.
Advances in multi-omics technologies such as genomics and proteomics are highlighted as transforming research on Ménière's disease. These methods have identified molecular pathways linked to immune activation, oxidative stress, abnormal ion transport, extracellular matrix remodeling, and altered nerve signaling—findings that may help identify biomarkers for diagnosis or targets for treatment.
The review notes increasing evidence supporting an important role for immune system activity in progression of Ménière's disease through inflammatory signaling or viral infections affecting the endolymphatic sac. Genetic discoveries are also revealing inherited variants associated with both familial and sporadic forms of this disorder.
